Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations

Abstract

Preventing ADRs is advisable in order to realize significant nationwide savings potential. Our cost estimates provide a reliable benchmark as they were calculated based on an intensified ADR surveillance and an accurate person-related cost application.